Behavioral changes and [123I]IBZM equilibrium SPECT measurement of amphetamine-induced dopamine release in rhesus monkeys exposed to subchronic amphetamine

Neuropsychopharmacology

Volumn 22, Issue 1, 2000, Pages 4-13

  Castner, Stacy A ^a   Al Tikriti, Mohammed S ^a   Baldwin, Ronald M ^a   Seibyl, John P ^a   Innis, Robert B ^a   Goldman Rakic, Patricia S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Animal model; Behavioral sensitization; D2 dopamine receptors; IBZM; Primates; Psychomotor stimulants; Stereotyped behavior; Striatum

Indexed keywords

DEXAMPHETAMINE; DOPAMINE 2 RECEPTOR; 3 IODO 2 HYDROXY 6 METHOXY N ((1 ETHYL 2 PYRROLIDINYL)METHYL)BENZAMIDE; 3-IODO-2-HYDROXY-6-METHOXY-N-((1-ETHYL-2-PYRROLIDINYL)METHYL)BENZAMIDE; BENZAMIDE DERIVATIVE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; PYRROLIDINE DERIVATIVE; RADIOACTIVE IODINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DRUG EFFECT; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEREOTYPY; ANIMAL; CEREBELLUM; DRUG ADMINISTRATION; MACACA; METABOLISM; MOTOR ACTIVITY; SCINTISCANNING;

ANIMALS; BENZAMIDES; CEREBELLUM; CORPUS STRIATUM; DEXTROAMPHETAMINE; DOPAMINE; DOPAMINE ANTAGONISTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; INJECTIONS, INTRAVENOUS; IODINE RADIOISOTOPES; MACACA MULATTA; MALE; MOTOR ACTIVITY; PYRROLIDINES; RECEPTORS, DOPAMINE D2; STEREOTYPED BEHAVIOR; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0033621585     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(99)00080-9     Document Type: Article

References (31)

1. Abi-Dargham A., Gil R., Krystal J., Baldwin R.M., Seibyl J.P., Bowers M., van Dyck C.H., Charney D.S., Innis R.B., Laruelle M. Increased striatal dopamine transmission in schizophrenia. Confirmation in a second cohort Am J Psychiatry. 155(6):1998;761-767.
2. Baldwin R.M., Zea-Ponce Y., Zoghbi S.S., Al-Tikriti M.S., Seibyl J.P., Sybirska E.H., Malison R.T., Laruelle M., Charney D.S., Hoffer P.B., Innis R.B. IBF, [123I]epidepride, and [123I]2′-ISP in nonhuman primates. Nucl Med Biol. 21:1994;969-976. [123I].
3. Bickerdike M.J., Abercrombie E.D. Striatal acetylcholine release correlates with behavioral sensitization in rats withdrawn from chronic amphetamine. J Pharmacol Exp Ther. 282(2):1997;818-826.
4. Breier A., Su T.P., Saunders R., Carson R.E., Kolachana B.S., de Bartolomeis A., Weinberger D.R., Weisenfeld N., Malhotra A.K., Eckelman W.C., Pickar D. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations. Evidence from a novel positron emission tomography method Proc Natl Acad Sci USA. 94(6):1997;2569-2574.
5. Castner S.A., Goldman-Rakic P.S. Long-lasting psychotomimetic consequences of repeated low dose amphetamine exposure in rhesus monkeys. Neuropsychopharmacology. 20(1):1999;10-28.
6. Duman R.S., Tallman J.F., Nestler E.J. Acute and chronic opiate-regulation of adenylate cyclase in brain. Specific effects in locus coeruleus J Pharmacol Exper Ther. 246(3):1988;1033-1039.
7. Ellison G., Eison M.S., Huberman H.S., Daniel F. Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration. Science. 201(4352):1978;276-278.
8. Ellison G., Ratan R. The late stage following continuous amphetamine administration to rats is correlated with altered dopamine but not serotonin metabolism. Life Sci. 31(8):1982;771-777.
9. Holman B.L., Carvalho P.A., Zimmerman R.E., Johnson K.A., Tumeh S.S., Smith A.P., Genna S. Brain perfusion SPECT using an annular single crystal camera. Initial clinical experience J Nucl Med. 31(9):1990;1456-1461.
10. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug and stress induced sensitization of motor activity. Brain Res Rev. 16:1991;223-244.
11. Kuczenski R., Segal D. Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J Neurosci. 9(6):1989;2051-2065.
12. Kuczenski R., Segal D.S. In vivo measures of monoamines during amphetamine-induced behaviors in rats. Prog Neuro-Psychopharmacol Biol Psychiatry. 14(suppl):1990;S37-S50.
13. Kuczenski R., Segal D.S., Aizenstein M.L. Amphetamine, cocaine, and fencamfamine. Relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics J Neurosci. 11(9):1991;2703-2712.
14. 123I]IBZM. A potential dopamine D-2 receptor imaging agent J Label Compound Radiopharmacol. 27:1989;691-700.
15. 123I-Iomazenil binding to bezodiazepine receptors in nonhuman primates. II. Equilibrium analysis of constant infusion experiments and correlation with in vitro parameters. J Cerb Blood Flow Metab. 14:1994;453-465. a.
16. 123I-iodobenzofuran and single photon emission computarized tomography. Eur J Pharmacol. 263:1994;39-51. b.
17. Laruelle M., Abi-Dargham A., van Dyck C.H., Gil R., D'Souza C.D., Erdos J., McCance E., Rosenblatt W., Fingado C., Zoghbi S.S., Baldwin R.M., Seibyl J.P., Krystal J.H., Charney D.S., Innis R.B. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA. 93(17):1996;9235-9240.
18. Laruelle M., Iyer R.N., Al-Tikriti M.S., Zea-Ponce Y., Malison R., Zoghbi S.S., Baldwin R.M., Kung H.F., Charney D.S., Hoffer P.B., Innis R.B., Bradberry C.W. Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates. Synapse. 25(1):1997;1-14.
19. Melega W.P., Raleigh M.J., Stout D.B., Lacan G., Huang S.C., Phelps M.E. Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey. Brain Res. 766(1-2):1997;113-120.
20. Miserendino M.J., Nestler E.J. Behavioral sensitization to cocaine. Modulation by the cyclic AMP system in the nucleus accumbens Brain Res. 674(2):1995;299-306.
21. Nestler E.J. Cellular responses to chronic treatment with drugs of abuse. Crit Rev Neurobiol. 7(1):1993;23-39.
22. Nestler E.J., Aghajanian G.K. Molecular and cellular basis of addiction. Science. 278(5335):1997;58-63.
23. Paulson P.E., Camp D.M., Robinson T.E. Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology. 103(4):1991;480-492.
24. Proakis A.G., Harris G.B. Comparative penetration of glycopyrrolate and atropine across the blood-brain and placental barriers in anesthetized dogs. Anesthesiology. 48(5):1978;339-344.
25. Ridley R.M., Baker H.F., Owen F., Cross A.J., Crow T.J. Behavioural and biochemical effects of chronic treatment with amphetamine in the vervet monkey. Neuropharmacology. 22(4):1983;551-554.
26. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration. A review and evaluation of animal models of amphetamine psychosis Brain Res. 396(2):1986;157-198.
27. Terwilliger R.Z., Beitner-Johnson D., Sevarino K.A., Crain S.M., Nestler E.J. A general role for adaptations in G-proteins and the cyclic AMP system in mediating the actions of morphine and cocaine on neuronal function. Brain Res. 548(1-2):1991;100-110.
28. Villemagne V., Yuan J., Wong D.F., Dannals R.F., Hatzidimitriou G., Mathews W.B., Ravert H.T., Musachio J., McCann U.D., Ricaurte G.A. Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans. Evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations J Neurosci. 18(1):1998;419-427.
29. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Gatley S.J., Hitzemann R., Chen A.D., Dewey S.L., Pappas N. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature. 386(6627):1997;830-833.
30. Williams S.M., Goldman-Rakic P.S. Widespread origin of the primate mesofrontal dopamine system. Cerebr Cortex. 8:1998;321-345.
31. Zubal I.G., Harrell C., Woods S.W., Innis R.B., Hoffer P.B., Caride V.J., Zimmermann R.E. Comparison of quantitation linearity of three brain SPECT imaging instruments using Tc-99m and 123I. J Nucl Med. 31:1990;769-770.